need for contraception among married women in an urban slum of Nagpur.
Typically, research studies on unmet
need for contraception estimate levels among married women and assume that their reports about fertility intentions and contraceptive use represent those of couples.
4% of children below 200% of poverty had unmet
medical needs, compared with 2.
is a cardiovascular drug discovery and development company focused on developing effective therapeutics for unmet
needs in the field of cardiovascular medicine.
The analysis should include financial-aid-related information (need level, amount of unmet
need, changes in aid from year to year, scholarship eligibility, etc.
is a biotechnology-based drug discovery company using its expertise in the fields of tissue fibrosis, connective tissue growth factor (CTGF), and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for fibrotic disorders, diabetic complications, anemia, conditions associated with tissue damage or injury, cancer, and other areas of unmet
Over the last three decades, recommendations have been made to improve the concept of unmet
need, including accounting for the need for more effective family planning among women using traditional methods, (8), (9) pregnant and postpartum women's future fertility intentions, (10) husbands' preferences and the unmet
need of the couple, (11), (12) and the unique contraceptive needs of unmarried women.
India, the first country in the world to start a national wide FP program, is still not able to fulfill the unmet
need of FP.
Despite the multifactorial components comprising the construct of unmet
needs, most research uses a crude (dichotomous) measure of unmet
Conclusion: Although there is high unmet
need of family planning and low contraceptive prevalence rate (CPR)among illiterate working women, having a paid job seems to improve female's control on family planning issues when compared to CPR of illiterate women in general.
needs for ancillary services were defined as services that participants reported needing, but not receiving during the 12 months before the interview.
With the unmet
needs of AML patients remaining critically high, what R&D strategies and opportunities are being used by drug makers to remain competitive?